NCT04501991View on ClinicalTrials.gov

Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

May 4, 2020

Study Completion Date

June 30, 2020

Conditions
Type 2 DiabetesMetabolic Control
Interventions
OTHER

antidiabetic treatment

Every kind of antidiabetic treatment, oral or injective, were considered including patients treated only with diet

Trial Locations (1)

56125

University of Pisa, Pisa

All Listed Sponsors
lead

University of Pisa

OTHER

NCT04501991 - Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes | Biotech Hunter | Biotech Hunter